Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Teva Pharmaceutical Industries Limited (TEVA)

12.7   -0.49 (-3.71%) 02-24 16:02
Open: 12.58 Pre. Close: 13.19
High: 12.98 Low: 12.21
Volume: 25,976,256 Market Cap: 13993M
Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.008 - 13.086 13.086 - 13.144
Low: 12.031 - 12.13 12.13 - 12.204
Close: 12.565 - 12.717 12.717 - 12.83

Technical analysis

as of: 2020-02-24 4:47:46 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 16.07     One year: 18.77
Support: Support1: 11.15    Support2: 9.54
Resistance: Resistance1: 13.76    Resistance2: 16.07
Pivot: 12.50
Moving Average: MA(5): 12.99     MA(20): 11.94
MA(100): 9.66     MA(250): 10.36
MACD: MACD(12,26): 0.75     Signal(9): 0.72
Stochastic oscillator: %K(14,3): 79.88     %D(3): 82.55
RSI: RSI(14): 60.40
52-week: High: 17.48  Low: 6.07  Change(%): -25.0
Average Vol(K): 3-Month: 1800416  10-Days: 2905922

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
TEVA has closed below upper band by 41.7%. Bollinger Bands are 23.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 24 Feb 2020 14:40:00 +0000
Warren Buffett's 2 Pure-Play Pharma Picks Are Real Head-Scratchers

Wed, 19 Feb 2020 11:40:11 +0000
Positive Catalysts Make Amarin Stock a Buy on Current Weakness

Wed, 19 Feb 2020 10:01:01 +0000
Opioids Made TEVA Stock Untouchable But Things Seem to be Changing

Thu, 20 Feb 2020 14:13:44 +0000
Health Care Sector Update for 02/20/2020: TOCA, FMS, TEVA, JNJ, ABT, MRK, PFE, AMGN

Wed, 19 Feb 2020 19:58:00 +0000
FDA Approved 1,014 Generic Drugs in 2019

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 1090.00
Shares Float (M) 1090.00
% Held by Insiders 0.48
% Held by Institutions 54.58
Shares Short (K) 57460
Shares Short P. Month (K)

Stock Financials

EPS -0.920
Book Value (p.s.) 12.800
PEG Ratio -1.29
Profit Margin -5.92
Operating Margin 16.11
Return on Assets (ttm) 2.9
Return on Equity (ttm) -6.5
Qtrly Rev. Growth -2.0
Gross Profit (p.s.) 6.917
Sales Per Share
EBITDA (p.s.) 4.073
Qtrly Earnings Growth
Operating Cash Flow (M) 748.00
Levered Free Cash Flow (M) 2250.00

Stock Valuations

P/E -13.80
P/E Growth Ratio -0.04
P/BV 0.99
P/S 0.82
P/CF 18.51

Dividends & Splits

Dividend Yield
Dividend Pay Date 2017-12-11
Ex-Dividend Date 2017-11-26
Forward Dividend
Last Split Date
Last Split Ratio 2
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.